Shuangzhu Liu
Jiangsu Key Laboratory Of Hematologic Diseases
Suzhou, China
Suzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The clinical characteristics and prognosis analysis of acute B-cell lymphoblastic leukemia with MEF2D fusions.
Journal: Annals of hematology
Published: August 19, 2025
The Application of Personalized Conditioning Regimens in Relapsed/Refractory Acute Myeloid Leukemia Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
Journal: Transplantation proceedings
Published: March 04, 2025
Efficacy of emapalumab in the management of anti‑CD19 chimeric antigen receptor T‑cell therapy‑associated cytokine release syndrome: A report of two cases.
Journal: Oncology letters
Published: August 09, 2024
Tislelizumab augment the efficacy of CD19/22 dual-targeted chimeric antigen receptor T cell in advanced stage relapsed or refractory B-cell non-Hodgkin lymphoma.
Journal: Hematological oncology
Published: July 04, 2023
Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease.
Journal: Signal transduction and targeted therapy
Published: October 13, 2021
Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Journal: Scientific reports
Published: October 23, 2017
Inhibition of Acute Graft-versus-Host Disease with Retention of Graft-versus-Tumor Effects by Dimethyl Fumarate.
Journal: Frontiers in immunology
Published: July 25, 2017
Showing 1-8 of 8
Last Updated: 09/26/2026